chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Migratory arthritis starting with the right knee, moving to the right ankle and calf, then to the left knee and left shoulder with resolution of the right.
Started with pain at injection site the day after vaccine was given.  The following day (2 days after vaccine), there was a quarter size bump and it was tender when touched.  At one week, the site was no longer tender but still erythema surrounding injection site, slightly larger.  At 2 weeks, noticed bump was more diffuse had spread (~4-5 cm) with more noticeable erythema around the edges.  Contacted employee health at this time who advised me to contact my PCP and submit VAERS report.  No fever or other systemic reactions during this period. Unsure if 2nd vaccine should be given.
CHILD'S DATE OF BIRTH WRITTEN AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY INDIVIDUAL IDENTIFYING AS MOM. CHILD IDENTIFIED WITH DATE OF BIRTH LISTED. CHILD TOO YOUNG TO RECEIVE VACCINE.
Itchy hands and feet and swollen armpit. Treating with Benadryl and symptoms are stable.
She had low grade fever of 102 that lasted approximately 48 hours. She also developed a full body rash - head to toe - the lasted approximately 6 days.
9/25/18 Pt called reporting pain and was couseling that pain may occur and to take an otc such as tylenol. She reported no redness no swelling no heat. She stated that she could not take any otc meds as she had maxed out her prescription med for the day. 9/26/18 She picked up her prescriptions at thr drive up window. One hour later she called to complain that the pain was so bad she was unable to drive for the past two days. She was not receptive to advise nor counseling per protochol.
Patient received her second dose of the Pfizer vaccine on 4/28/21 at approximately 7pm. While waiting in the waiting area for 15 minutes after getting the vaccine, she reported feeling chest pain and dizziness. She agreed to have us call the ambulance for her, they came quickly and took her to the hospital. I asked the EMT worker which hospital they were taking her to, but he said he cannot disclose the information. Patient also mentioned that she has hypertension and is on blood pressure medications.
Patient reported rash on upper arm near the injection site, Patient also said that she had experienced nausea and vomiting.
Employee was fully vaccinated on 1/26/2021 and 1/28/2021 with Pfizer, and on 8/13/2021 became ill and tested positive for COVID
Headache, Myalgia, Fever, weakness, tender at injection site Narrative:
Patient's mother stated her son was 12 years old and wanted to get the COVID-19 vaccine. Filled out the form; verified age with patient; administered the vaccine. When processing the form, rejected thru insurance because patient was under the age of 12. Pharmacy did not have vaccine for <12 years old. Administered wrong Pfizer vaccine.
This spontaneous report as received from a licensed vocational nurse refers to a 71 year old male patient with diabetes, chronic kidney disease, hypertension and drug reactions or allergies to Benazepril hydrochloride. The patient will be getting a kidney transplant on an unspecified date. The patient's medical history included bypass surgery. The patient was vaccinated with dose 1 of 10 Microgram RECOMBIVAX HB (lot # 660951/0398X, expiration date 18-NOV-2010) intramuscularly on 28-JAN-2009, with dose 2 of 40 microgram (dialysis formulation) RECOMBIVAX HB (lot # reported as 1696X, expiration date 27-JUN-2011) on 02-MAR-2009, with dose 3 of 40 microgram (dialysis formulation) RECOMBIVAX HB (lot # reported as 1696X, expiration date 27-JUN-2011) on 24-AUG-2009 and with dose 4 of 40 microgram (dialysis formulation) RECOMBIVAX HB (lot # reported as 1696X, expiration date 27-JUN-2011) on 13-OCT-2009. No other co-suspects were reported. Concomitant medications included Sertraline hydrochloride, Clonazepam, LIPITOR and Diphenhydramine hydrochloride. On an unknown date, the patient was showing to be "non-immune" to hepatitis B. The reporting nurse explained that the patient had received dose 1 of RECOMBIVAX HB and shortly afterwards (unspecified date) the patient informed the physician that he would be going on dialysis ("patient is on dialysis" was also reported as pertinent medical history). No treatment information was reported. The patient sought unspecified medical attention. At the time of the report the patient's outcome of dialysis was unknown. The patient's present status was reported as "non-immune" to hepatitis B. Upon internal review, dialysis was considered to be an other important medical event. The patient also experienced drug allergy while on COZAAR on an unspecified date (MARRS #1209USA003112). Additional information has been requested.
Information has been received from a physician concerning a 16 year old female patient with a history of seizure disorders who in approximately 15-NOV-2008 "about a month ago", was vaccinated with a second 0.5ml dose of GARDASIL.  The physician reported that the patient experienced a seizure after receiving the vaccine.  The patient sought unspecific medical attention.  The patient recovered within a few minutes.  Upon internal review seizure disorders were considered as an other important medical event.  Additional information has been requested.
Abrupt onset of vertigo; Some element of confusion; "Felt a weird sense of disassociation with this around"; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Mar2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included biotin (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), spironolactone (ALDACTONE) and cannabidiol (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 07Apr2021, the patient underwent lab tests and procedures which included nasal swab test and the result was negative. On 11Apr2021 at 08:00, the patient experienced abrupt onset of vertigo, some element of confusion and felt a weird sense of disassociation with this around her. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event abrupt onset of vertigo, some element of confusion and "Felt a weird sense of disassociation with this around" was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Allergic Reaction; swelling of the eyes; swelling of the mouth; facial swelling; patient crossed the window period for receiving the 2nd dose of vaccine; headache; fever of 104F, in ER fever of101F; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic Reaction), EYE SWELLING (swelling of the eyes), MOUTH SWELLING (swelling of the mouth), SWELLING FACE (facial swelling) and PRODUCT DOSE OMISSION ISSUE (patient crossed the window period for receiving the 2nd dose of vaccine) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced ALLERGY TO VACCINE (Allergic Reaction), EYE SWELLING (swelling of the eyes), MOUTH SWELLING (swelling of the mouth), SWELLING FACE (facial swelling), PRODUCT DOSE OMISSION ISSUE (patient crossed the window period for receiving the 2nd dose of vaccine), HEADACHE (headache) and PYREXIA (fever of 104F, in ER fever of101F). The patient was treated with PREDNISONE for Allergic reaction, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, ALLERGY TO VACCINE (Allergic Reaction), EYE SWELLING (swelling of the eyes), MOUTH SWELLING (swelling of the mouth), SWELLING FACE (facial swelling), HEADACHE (headache) and PYREXIA (fever of 104F, in ER fever of101F) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (patient crossed the window period for receiving the 2nd dose of vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (High) 104F and 101 (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided  Treatment medications Oral steroid for 6 days  Patient was recommended to take Benadryl medication   This case was linked to MOD-2021-264306 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: No new information was added regarding first dose
Received first Pfizer Covid-19 vaccine on 12/28/2020 and second dose on 01/18/2021.  On 02/09/2021 I was diagnosed with shingles on my left/mid back.  I was able to send pictures to my doctor's office for diagnosis and am now on day two of treatment with Valacyclovir.  Condition likely caught early, but symptoms (rash, pain) are worsening as of today.
This spontaneous report as received from a other health physician assistant, regarding a 12 year old male patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 08-NOV-2017, the patient was vaccinated with GARDASIL 9 intramuscularly, lot # N017832 with expiration date on 16-NOV-2019 (strength, dose and frequency were not reported) for prophylaxis. On the same date just 5 seconds after vaccination, the patient had a syncopal episode, and as reported he was "out for 10 seconds". His blood pressure and oximetry were checked and by the time of this report the patient was doing fine. The causal relationship between vaccination with GARDASIL 9 and the syncopal episode was not mentioned by the reporter.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug reaction/allergies and concomitant medications was not reported. On  23-JUN-2016, the patient was vaccinated with an expired dose of GARDASIL (lot # K023432, expiration date: 18-JUN-2016) 0.5 ml, intramuscularly. No adverse effects were reported. There was no product quality complaint. Additional information has been requested.
Weakness, lightheaded, high blood pressure, inability to take deep breath, less able to breath lying down - needed to sit up. Diagnosed at Hospital with Pericarditis. Treatments: MRI of  head and chest, EKG, Nitroglycerin, Echo cardiogram, blood test, prescription to cure inflamation of sack around heart. Greatly improved in 2 days. Final stress test and blood test showed pericarditis resolved.
Large welt at injection site; Area is hot and arm is very sore.; Area is hot and arm is very sore.; This is a spontaneous report from a contactable consumer. This consumer reported for himself that,  A 15-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0191) (at the age of 15 years old), dose 2 via an unspecified route of administration, administered in arm left on 09Jun2021 17:45 as dose 2, single for covid-19 immunisation. Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0185), dose 1 via an unspecified route of administration, administered in arm left on 19May2021 16:45 as dose 1, single for covid-19 immunisation. Medical history included attention deficit hyperactivity disorder from an unknown date and unknown if ongoing, tourette's disorder from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing, bursitis from an unknown date and unknown if ongoing. Concomitant medication(s) included Multi-Vitamins, methylphenidate hydrochloride (CONCERTA) taken for an unspecified indication, start and stop date were not reported; fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported; ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication, start and stop date were not reported. It was reported that on 10Jun2021 at 12:15 patient experienced large welt at injection site, area was hot and arm was very sore. No treatment was received for events. Patient did not have covid prior to vaccination. He was not tested for covid post vaccination. The outcome for the events was not recovered.  Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected.
A physician reported that a 9 month old female received Prevnar and Hep-B vaccines on 5/22/00. Sixteen hours, post vax, the infant developed a fever up to 102.3F. Twenty hours, post vax, she developed a generalized tonic-clonic seizure lasting 1 to 2 minutes. The fever resolved within 2 hours of the seizure. The reporter noted that the infant was well within 24 hours and that the seizure did not reoccur.
Swelling at (L) arm 1 day after MENACTRA and FLUZONE vaccine 4 x 4 in.
The day after immunizations the patient had 2 episodes, 1 minute each, with her head dropping back and to the left, staring straight ahead. The patient was unresponsive with a droop to the left face. There were no limb movements.
It was discovered that patient was administered the covid vaccine dosage for a 4 year old.  No adverse side effects noted.   Mom agreed to reschedule
the day following vax pt exp fatigue & nausea. that eve pt exp a fever & varicella like rash on left arm & was described as tiny vesicles & maculopapular lesions.
This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (very mild burning sensation in the arm after tbe second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (very mild burning sensation in the arm after tbe second dose). At the time of the report, BURNING SENSATION (very mild burning sensation in the arm after tbe second dose) outcome was unknown. No concomitant medications were reported. No treatment information was reported.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 24-APR-2014 the patient was vaccinated with MMR II (strength, dosage and route were not reported) lot number: J009706, expiration date: 15-AUG-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the MMR II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was an any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Hand swelled; Swelled especially knuckles; Stiffness in all knuckles especially middle finger, looked like baseball mitt, knuckles felt "fused"; Pain in all knuckles especially middle finger; First dose and second dose administered to patient on 08Mar2021; This is a spontaneous report from a contactable consumer(patient). A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 08Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS), environmental allergy, depression, arthritis and cold sores from unknown start date and unknown if ongoing. The patient previously received BACTRIUM, KEFLEX, lisinopril, benzodiazepines (BZDs) and experienced allergy from unknown start date and unknown if ongoing. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), acyclovir (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN), nefazodone (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) for unspecified indication start dates and stop dates were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in left arm on 08Mar2021(same date with first dose) (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021 at 12:30 (23 hours after injection), the patient experienced right hand swelling especially in knuckles, pain/stiffness in all knuckles especially the middle finger which looked like baseball mitt and knuckles felt fused. The patient was unable to bend middle finger at all or grasp for 2 weeks. Therapeutic measures were taken because of the events which included treatment with ice, diclofenac and TYLENOL, but there was no pain/swelling relief from ice, diclofenac or TYLENOL. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of right hand swelling especially in knuckles, pain/stiffness in all knuckles especially the middle finger was resolving at the time of report.No follow-up attempts are needed. No further information is expected.
Smaller flare up of original diagnosis purpura anularis telangiectodes (purple spots). Treatment is to continue supplements prescribed/recommend before: Vitamin C and Rutin.
Woke up at 4:00 am (13.5 hours after vaccine) with muscle aches, chills, and shaking. Took 2 Tylenol at 4:45 am, ate a snack, and wrapped up in blankets. Significant relief from symptoms at 5:20 am. Went back to sleep. The following day, I had a mild headache, mild arm soreness, mild sinus congestion, and moderate tiredness.
COVID Breakthrough. Patient tested positive for COVID on 2/24/22and is asymptomatic.
The vaccine expired (11-11/21) over the weekend. The MMRV vaccine was given to child a few days after expiration date. No adverse reaction.
Sounding Delusional; Felt Dizzy; Running a Fever; This spontaneous case was reported by a consumer and describes the occurrence of DELUSIONAL DISORDER, UNSPECIFIED TYPE (Sounding Delusional), DIZZINESS (Felt Dizzy) and PYREXIA (Running a Fever) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 025j20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced DELUSIONAL DISORDER, UNSPECIFIED TYPE (Sounding Delusional), DIZZINESS (Felt Dizzy) and PYREXIA (Running a Fever). At the time of the report, DELUSIONAL DISORDER, UNSPECIFIED TYPE (Sounding Delusional) and DIZZINESS (Felt Dizzy) outcome was unknown and PYREXIA (Running a Fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.6 (High) increased and 98 (normal) normal.         On 19 Feb 2021, after the second dose of vaccination, patient felt almost like alzheimers, dizzy, running a fever, sounding delusional and having a hard time. Patient experienced a temperature of 100.6 which came down to 98 degrees. Treatment information included tylenol to bring down the fever. Company comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Patient presented to the emergency department with a chief complaint of a generalized fatigue and shortness of breath. Patient reported to have tested positive for COVID-19 a week ago after developing flu-like symptoms.  She received on 02/09/2022 monoclonal antibodies following which she her shortness of breath got worse associated with generalized fatigue and episode of fever.   Denied any chest pain, syncope, abdominal pain, nausea and vomiting.  She had a temperature of 100.7 degree F, mildly tachypneic.  No hypoxemia saturating 96%  on pulse oximeter.  Chest x-ray was negative for acute process.
patient came into pharmacy complaining of redness and warmth to skin around injection site, told patient to apply ice pack and take some Tylenol for discomfort and follow up tomorrow with.  I will contact patient tomorrow and check on her
A week after the patient had the vaccine he developed weakness with numbness in the lower extremities. Patient continued to get worse and was admitted on 04/03 with concerns for Guillain-Barré syndrome ( GBS). Patient is currently getting treatment for GBS.
Information has been received from a nurse concerning unspecified patients of unknown age and gender. On unspecified dates, the patients were administered with ROTATEQ (dose and route not provided, lot # L029934 with expire date of 01-MAY-2017), which was exposed to temperatures outside of the recommended range (incorrect product storage). The conditions storage was 11 Celsius degree for 1333 hours, 41 minutes. There was no previous temperature excursion. No adverse effects have been reported. Additional information has been requested.
Burning sensation in hands, chronic on and off. Lump in neck/clavicle area.
Sore arm; Booster; This is a spontaneous report from a non-contactable consumer or other non hcp. A 75-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 3 via an unspecified route of administration on an unspecified date as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included pirfenidone (ESBRIET). Historical Vaccine included BNT162B2 as dose 1 and dose 2 on an unspecified date for COVID-19 immunization (at the age of 75-years-old). The patient experienced sore on an unspecified date. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.